Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis.
Giordano SigonRoberta D'AmbrosioMariagrazia ClericiGiuseppina PisanoVeena ChantarangkulRoberta SollazziRosa LombardiFlora PeyvandiPietro LamperticoSilvia FargionArmando TripodiAnna Ludovica FracanzaniPublished in: Liver international : official journal of the International Association for the Study of the Liver (2019)
Patients with HCV infection, even in the absence of cirrhosis have a procoagulant-imbalance that possibly plays a role in increasing the risk of cardiovascular disease and progression of fibrosis.